Form 8-K - Current report:
SEC Accession No. 0001157523-21-001314
Filing Date
2021-11-03
Accepted
2021-11-03 07:30:27
Documents
13
Period of Report
2021-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CHARLES RIVER LABORATORIES INTERNATIONAL, INC. 8-K a52520056.htm   iXBRL 8-K 27803
2 EXHIBIT 99.1 a52520056ex99_1.htm EX-99.1 678998
  Complete submission text file 0001157523-21-001314.txt   879853

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA crl-20211103.xsd EX-101.SCH 3914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE crl-20211103_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crl-20211103_pre.xml EX-101.PRE 16037
6 EXTRACTED XBRL INSTANCE DOCUMENT a52520056_htm.xml XML 4077
Mailing Address 251 BALLARDVALE ST WILMINGTON MA 01887
Business Address 251 BALLARDVALE ST WILMINGTON MA 01887 781-222-6000
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (Filer) CIK: 0001100682 (see all company filings)

EIN.: 061397316 | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-15943 | Film No.: 211373735
SIC: 8731 Services-Commercial Physical & Biological Research